#acr19 ⁦@RheumNow⁩ Dr West’s Pearls: - at 40x magnification of synovial fluid, 1 WBC per hpf = 500 WBC/ uL (hence, 5 WBCs seen= 2500 WBC/uL which means the pt has an inflammatory fluid - you don’t have to wait for the lab results!) https://t.co/nChSnFq5NL

The updated ACR/NPF treatment recommendations for PsA were discussed by Dr. Mease and Dr. E. Husni at #ACR19. Will you start with a TNFi, as per these recommendations, over other medications for your tx naive patients? @RheumNow

Nice work showing PROs correlate with high disease activity in pts w/checkpoint inhibitor-related inflammatory arthritis abstr#2151 @cappelliMD @LCalabreseDO @RheumNow #ACR19 #cleclinicrheum https://t.co/Yi8LhNhA0v

500 patients with CVID -94% had infections -30% had autoimmunity -30% had chronic lung disease -10% had granulomatous disease -Dr. Mahta Mortezavi Need I convince you any further to consider CVID when evaluating your patients with rheumatic disease? #ACR19 @RheumNow

#ACR19 poll: Do you use Prednisone to manage symptoms of hand osteoarthritis? @RheumNow

Nice job @didemsayginmd ! Abstr#2144 single center rheumatic irAE experience - 50% required ICI interruption! 20% needed DMARDs @RheumNow #ACR19 #cleclinicrheum https://t.co/dGaIaKzYFS

@rheumnow #ACR19 ABS2594 prospective cohort study of 56 early cutaneous SSc pts found no association between ETAR &AT1R Abs positivity & vascular complications making ETAR &AT1R abs unlikely prognostic markers of Vasc complications #acrbest https://t.co/e9kNSFeBOx

Some immunodeficiencies present primarily with autoimmune or lymphoproliferative features…hence the need to consider immunodeficiency in patients with suspected rheumatic disease. Dr. Mahta Mortezavi #ACR19 @RheumNow

@DBrandmanMD speaking at #ACR19 on NAFLD: HOW MUCH WEIGHT LOSS to do you need to improve/reverse stages of #FattyLiver? >3% for steatosis >5% for NASH improvement >7% for NASH resolution >10% for cirrhosis reversal (only 10% of pts get there) @RheumNow @ACRheum

As recommended by @doctorswade's research, Dr. Mahta Mortezavi recommends checking baseline immunoglobulins prior to rituximab use. #ACR19 @RheumNow https://t.co/EMapSb0tTW

@RheumNow 5T063 Immunodeficiency for the Rheumatologist: immune defects and corresponding clincial features https://t.co/iUvjP6hNdY

Gut microbiome-altering drugs like steroids, PPIs and antibiotics had negative effect on tumor response when given prior to checkpoint inhibitor therapy abstr#1811 @RheumNow @cappelliMD @LCalabreseDO #acr19 #cleclinicrheum

Dr. Mease discusses the ACR/NPF recommendations for treatment naive PsA pts. This slide details starting with TNFi for patients. #ACRbest #ACR19 @RheumNow https://t.co/0GZ2RFPWjW

Romo increased BMD across eGFR subgroups vs Pbo. Reduction in new vertebral fractures not affected by eGFR. https://t.co/HMkREcwoQj #ACR19 @RheumNow plenary#2730 #ACRbest https://t.co/9ojwhmmZxx

• Efficacy and Safety of Romosozumab vs Placebo Among Patients with Mild-to-Moder…

Abstr# 2160: Myopenia is associated with risk of rotator cuff tearing in the elderly. A great reminder to encourage exercise and building muscle mass to our patients. #ACR19 @RheumNow https://t.co/w5WrL6YcD7